Form D · Other
RivalHealth, LLC
Raleigh, NC · CIK 0001584624
Offering snapshot reported Mar 6, 2015 · SEC filing
- Reported sold
- $827K Offering amount: $1.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Feb 20, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2015 | Initial | $827,000 | No comparison | 4 | SEC filing |
| Nov 21, 2014 | Initial | $315,000 | No comparison | 2 | SEC filing |
| Aug 16, 2013 | Initial | $2,561,764 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-235359
Source: Form D, filed Mar 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Douglass | Director |
| Peter T. Durand | Director, Executive |
| Philip Lewis | Director |
| Todd Wiebusch | Director |
Issuer details
Industry: Other (See others in industry)
Address:
6601 Hillsborough St., Suite 109
Raleigh, NC, 27606
Raleigh, NC, 27606